• Catalent Divests Blow-Fill-Seal Sterile CDMO Business contractpharma
    January 08, 2021
    ​SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract development and manufacturing business from Catalent Pharma Solutions.
  • Bioclinica Acquires Saliency contractpharma
    January 07, 2021
    ​Bioclinica, an integrated solutions provider of clinical life science and technology expertise, has acquired Silicon Valley-based Saliency.
  • Aceto to Acquire IsleChem contractpharma
    January 05, 2021
    ​Aceto, a global virtual manufacturer of specialty materials for life sciences has acquired NY-based, IsleChem, a provider of chemical manufacturing, contract research and development (R&D), analytical services, and technical and support services.
  • Charles River Labs Acquires Distributed Bio contractpharma
    January 05, 2021
    ​Charles River Laboratories has acquired Distributed Bio, Inc. for $83 million in cash, subject to customary closing adjustments.
  • Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) prnewswire
    December 31, 2020
    Centene Corporation announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases.
  • Advanced Enzyme Technologies to acquire SciTech Specialties for Rs 316.26 million expresspharma
    December 28, 2020
    On completion of the aforesaid investment, Advanced Enzyme Technologies will get a controlling stake of 51 per cent in SciTech Specialties with a total shareholding of 520,408 equity shares.
  • Model N to acquire Deloitte’s Life Sciences pricing and contracting solutions business expresspharma
    December 21, 2020
    Model N announced that it has entered into a definitive agreement to acquire Deloitte’s life sciences pricing and contracting solutions business and underlying technology.
  • Novartis to acquire Cadent Therapeutics for $770 mn expresspharma
    December 18, 2020
    Novartis gains full rights to Cadent’s NMDAr allosteric modulator program, pre-clinical programs and clinical stage movement disorder program.
  • AstraZeneca to acquire Alexion expresspharma
    December 14, 2020
    AstraZeneca and Alexion Pharmaceuticals have entered into a definitive agreement for AstraZeneca to acquire Alexion.
  • LINK Medical Acquires IRW Consulting AB contractpharma
    December 10, 2020
    LINK Medical has acquired IRW Consulting AB (IRW), a Nordic CRO with more than 20 years of experience in clinical research outsourcing.
PharmaSources Customer Service